Evidence map›Paper›PMID 34592123›Full record

SynthesisExpert review of vaccines2021

COVID-19 vaccination in pregnant and lactating women: a systematic review.

Raffaele Falsaperla, Guido Leone, Maria Familiari, Martino Ruggieri

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Expert review of vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 4 pooled it
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 4 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Coronavirus Disease-2019 in Pregnancy.Clinics in chest medicine · 2023
    Review
  16. Vaccination from the early second trimester onwards gives a robust SARS-CoV-2 antibody response throughout pregnancy and provides antibodies for the neonate.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Observational
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Raffaele FalsaperlaNeonatal Intensive Care Unit, Auo Policlinico, 'Rodolico-san Marco' University of Catania, Italy.
Guido LeoneDepartment of Clinical and Experimental Medicine, Auo Policlinico 'Rodolico-san Marco' University of Catania University of Catania, Italy.
Maria FamiliariDepartment of Clinical and Experimental Medicine, Auo Policlinico 'Rodolico-san Marco' University of Catania University of Catania, Italy.
Martino RuggieriDepartment of Clinical and Experimental Medicine Section of Pediatrics and Child Neuropsychiatry, Auo Policlinico 'Rodolico-san Marco' University of Catania, Italy.
University of Catania · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe concern of undergoing vaccination during pregnancy and lactation, in absence of data on safety and efficacy in these target populations, is subject of ongoing debate nationally and internationally. However, the only real prophylactic strategy against COVID-19 is still mass vaccination, which means to vaccinate infants and pregnant and lactating women. AREAS COVERED: This is a systematic review aiming to evaluate the safety and the efficacy of COVID-19 vaccines in pregnant and lactating women and their newborns. We did advanced research on PubMed and Google Scholar, and searched for any evidence also on ClinicalTrials.gov. Results refer to a timeline going until 12 June 2021. EXPERT OPINION: Our efforts must be directed to vaccine more and more population groups which have been preliminarily excluded from the vaccination campaign. Studies have not so far highlighted plausible adverse effects in vaccinated pregnant women or in their newborns. Reactogenicity across lactating and pregnant women does not seem to differ from general population. Likewise, abortion rate does not differ from non-vaccinated pregnant women studied before the COVID-19 pandemic. It also seems that a major amount of anti-SARS-CoV-2 immunoglobulins is transferred through the placenta and the breastmilk to the newborn, providing humoral immunity.

Indexed as

COVID-19COVID-19 VaccinesVaccinationAntibodies, ViralFemaleHumansImmunity, Maternally-AcquiredInfant, NewbornLactationPandemicsPregnancyAntibodies, ViralCOVID-19 VaccinesbreastfeedingCOVID-19lactationPregnancyvaccines

Identifiers

PMID34592123
PMCPMC8515785
OpenAlexW3202078152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.